Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)

Market Cap	3.66B
Revenue (ttm)	349.61M
Net Income (ttm)	-2.00M
Shares Out	56.67M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	425,225
Average Volume	463,666
Open	65.00
Previous Close	64.71
Day's Range	63.88 - 65.45
52-Week Range	57.32 - 105.15
Beta	0.84
RSI	42.10
Earnings Date	Apr 19, 2025

About SHA:688399

Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. It offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. The company was founded in 2010 and is headquartered in Taizhou, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2010
• Employees: 592
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688399

Financial Performance

In 2024, SHA:688399's revenue was 349.61 million, a decrease of -13.29% compared to the previous year's 403.18 million. Losses were -2.00 million, -99.46% less than in 2023.